おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ILIAS Biologics
company
About
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $20.60M
- Industries
- Biopharma,Biotechnology,Medical Device
- Founded date
- Nov 2, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules. The company features platform technology that enables experts to load large therapeutic molecules into exosomes.ILIAS Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$20.60M
ILIAS Biologics has raised a total of
$20.60M
in funding over 2 rounds. Their latest funding was raised on
Sep 28, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 28, 2020 | Series B | $20.60M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
ILIAS Biologics is funded by 3 investors.
Asset One
and Genie Asset Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Asset One
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
